...
首页> 外文期刊>The Pediatric infectious disease journal >Antiretroviral regimens containing a single protease inhibitor increase risk of virologic failure in young HIV-infected children
【24h】

Antiretroviral regimens containing a single protease inhibitor increase risk of virologic failure in young HIV-infected children

机译:包含单一蛋白酶抑制剂的抗逆转录病毒疗法会增加艾滋病毒感染的儿童病毒学衰竭的风险

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rifampin-based tuberculosis treatment can cause subtherapeutic concentrations of protease inhibitors and virologie failure in children receiving antiretroviral therapy. Among 217 children on antiretroviral therapy, tuberculosis cotreatment (in 78) was associated with virologie failure. Ritonavir-based single protease inhibitor antiretroviral therapy regimen predicted virologie failure (adjusted odds ratio 3.7, 95% confidence interval 1.5-8.9, P= 0.004) on multivariate analysis.
机译:基于利福平的结核病治疗可导致接受抗逆转录病毒治疗的儿童亚治疗浓度的蛋白酶抑制剂和病毒学衰竭。在接受抗逆转录病毒治疗的217名儿童中,结核病共治疗(78名)与病毒学失败有关。在多变量分析中,基于利托那韦的单一蛋白酶抑制剂抗逆转录病毒治疗方案可预测病毒学失败(校正比值比3.7,95%置信区间1.5-8.9,P = 0.004)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号